» Articles » PMID: 2059879

Dexamethasone and 1,25(OH)2 Vitamin D3 Modulate the Synthesis of Insulin-like Growth Factor-I in Osteoblast-like Cells

Overview
Specialty Pathology
Date 1991 Apr 1
PMID 2059879
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we have shown that insulin-like growth factor-I (IGF-I) was released by primary cultures of rat osteoblast-like (ROB) cells into the conditioned medium (CM). Dexamethasone (DEX) caused a dose-dependent inhibition of the IGF-I. At 10(-8) M, DEX reduced IGF-I level to 70% of the control value (P less than 0.05); at 10(-7) M DEX, the IGF-I level was further reduced to 60% of the control (P less than 0.01). The active vitamin D metabolite 1,25-dihydroxycholecalciferol [1,25(OH)2D3] slightly increased the IGF-I level, but the increase was not statistically significant. However, in combined treatments of 10(-7) M DEX and 10(-8) M of 1,25(OH)2D3, the inhibition of DEX was partially antagonized by the presence of 1,25(OH)2D3. Studies with metabolically radiolabeled IGF-I by immunoprecipitation indicated the changes of IGF-I in the CM reflected synthesis of the protein by the cells. The alteration of IGF-I level may mediate some of the actions of these steroid hormones on bone cells.

Citing Articles

Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies.

Perez-Campo F, May T, Zauers J, Sanudo C, Delgado-Calle J, Arozamena J J Bone Miner Metab. 2016; 35(2):150-160.

PMID: 27038990 DOI: 10.1007/s00774-016-0753-z.


Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells.

Ramajayam G, Vignesh R, Karthikeyan S, Senthil Kumar K, Karthikeyan G, Veni S Mol Cell Biochem. 2012; 368(1-2):77-88.

PMID: 22673962 DOI: 10.1007/s11010-012-1345-4.


Vitamin D metabolism and action in human bone marrow stromal cells.

Zhou S, LeBoff M, Glowacki J Endocrinology. 2009; 151(1):14-22.

PMID: 19966181 PMC: 2803155. DOI: 10.1210/en.2009-0969.


Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.

Maruotti N, Corrado A, Grano M, Colucci S, Cantatore F Rheumatol Int. 2008; 29(6):667-72.

PMID: 18989673 DOI: 10.1007/s00296-008-0755-9.


Osteoblast differentiation of NIH3T3 fibroblasts is associated with changes in the IGF-I/IGFBP expression pattern.

Abdallah B Cell Mol Biol Lett. 2006; 11(4):461-74.

PMID: 17001448 PMC: 6275977. DOI: 10.2478/s11658-006-0038-y.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Furlanetto R, Underwood L, Van Wyk J, DErcole A . Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977; 60(3):648-57. PMC: 372409. DOI: 10.1172/JCI108816. View

3.
Chen T, Hauschka P, Cabrales S, Feldman D . The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology. 1986; 118(1):250-9. DOI: 10.1210/endo-118-1-250. View

4.
Stracke H, Schulz A, Moeller D, Rossol S, Schatz H . Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol (Copenh). 1984; 107(1):16-24. DOI: 10.1530/acta.0.1070016. View

5.
Canalis E, McCarthy T, Centrella M . Growth factors and the regulation of bone remodeling. J Clin Invest. 1988; 81(2):277-81. PMC: 329568. DOI: 10.1172/JCI113318. View